European Union – Intellectual property rights. The Court of Justice of the European Union dismissed the appeals by Novartis Europharm Ltd against two decisions of the General Court of the European Union by which the General Court had dismissed its actions against two decisions of the European Commission granting marketing authorisations for the medicinal products for human use 'Zoledronic acid Teva Pharma - zoledronic acid' and 'Zoledronic acid Hospira - zoledronic acid' Aclasta', respectively.